Bruker (BRKR) Accumulated Expenses (2010 - 2025)

Bruker (BRKR) has reported Accumulated Expenses for 16 consecutive years, with $179.7 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses fell 4.31% year-over-year to $179.7 million; the trailing twelve-month figure through Dec 2025 stood at $179.7 million (down 4.31% YoY), and the FY2025 full-year result was $179.7 million, down 4.31% from the prior year.
• Accumulated Expenses eased to $179.7 million in Q4 2025 per BRKR's latest filing, from $187.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $187.8 million in Q4 2024 and bottomed at $132.0 million in Q4 2021.
• Historically, Accumulated Expenses has averaged $160.4 million across 5 years, with a median of $166.5 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Accumulated Expenses increased 22.34% in 2023, then retreated 4.31% in 2025.
• Over 5 years, Accumulated Expenses stood at $132.0 million in 2021, then grew by 3.11% to $136.1 million in 2022, then rose by 22.34% to $166.5 million in 2023, then grew by 12.79% to $187.8 million in 2024, then decreased by 4.31% to $179.7 million in 2025.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $179.7 million, $187.8 million, and $166.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.